NCT00283478已完成不适用
Randomized Pilot Study of Supplemental Iscar in Combination With Gemcitabine vs. Gemcitabine Alone as Second Line Treatment for Advanced Non-Small Cell Lung Cancer.
Kentuckiana Cancer Institute2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2004年5月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
- 试验地点
- 2
- 主要终点
- To determine if Iscar improves immune function and quality of life.
研究概览
简要总结
To determine if Iscar Quercus improves immune function and quality of life among patients with stage IV non-small cell lung cancer.
详细描述
RAndomized pilot study of supplemental Iscar in combination with Gemcitabine vs. Gemcitabine alone as second line treatment for advanced non-small cell lung cancer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •newly diagnosed IIIB and IV NSCLC who have failed one prior line of chemo
- •Karnofsky score 60% or greater
- •patients who will be treated with Gemcitabine
排除标准
- 未提供
结局指标
主要结局
To determine if Iscar improves immune function and quality of life.
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
Iscar for Supplemental Care in Stage IV Lung CancerLung CancerNCT00079794National Center for Complementary and Integrative Health (NCCIH)36
Unknown
不适用
Iscador Qu as Supportive Treatment in Colorectal Cancer (Union International Cancer Control, UICC Stages II-IV)Colorectal CancerNCT01448655IFAG AG300
Unknown
不适用
Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV)Pancreas CancerNCT01448668IFAG AG220
Unknown
2 期
Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative ChemotherapyLung CancerNCT00052325Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
招募中
4 期
Safety and Modulation of Adaptive Immunity by Iscador® Qu Viscum Album Extract in Patients With Advanced, Recurrent or Metastatic Cancers Treated With Immune Checkpoint InhibitorsAdvanced Solid TumorNCT06408688University Hospital, Basel, Switzerland100